2021
DOI: 10.1007/s10840-021-00991-3
|View full text |Cite
|
Sign up to set email alerts
|

Differences in D-dimer blood concentration in atrial fibrillation patients with left atrial thrombus or severe left atrial spontaneous echo contrast

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 24 publications
1
5
0
Order By: Relevance
“…The use of oral anticoagulant drugs before D-dimer measurements increased the potential of normal range D-dimer levels in AF patients with LAT according to our results and previous paper. 18,19 Larger left atrial diameter was associated with increased D-dimer in AF patients with LAT in our study, which may be explained by D-dimer being a biomarker of degenerated fibrinogen during active thrombus formation, 20 which was more likely to be present and active in larger atria as shown in previous studies. 16,21 We found that the larger LAD was associated with increased D-dimer.…”
Section: Discussionsupporting
confidence: 77%
See 1 more Smart Citation
“…The use of oral anticoagulant drugs before D-dimer measurements increased the potential of normal range D-dimer levels in AF patients with LAT according to our results and previous paper. 18,19 Larger left atrial diameter was associated with increased D-dimer in AF patients with LAT in our study, which may be explained by D-dimer being a biomarker of degenerated fibrinogen during active thrombus formation, 20 which was more likely to be present and active in larger atria as shown in previous studies. 16,21 We found that the larger LAD was associated with increased D-dimer.…”
Section: Discussionsupporting
confidence: 77%
“…The use of oral anticoagulant drugs before D-dimer measurements increased the potential of normal range D-dimer levels in AF patients with LAT according to our results and previous paper. 18 , 19 …”
Section: Discussionmentioning
confidence: 99%
“…Stroke risk was assessed by the CHA 2 DS 2 ‐VASc score, which is calculated by adding the risk factors of congestive heart failure, hypertension, age 65–74 years or ≥75 years, diabetes mellitus, stroke or TIA, vascular disease, and female sex. Each parameter was weighted by “1,” except for stroke or TIA and age ≥75 years, which were weighted by “2.” 8 …”
Section: Methodsmentioning
confidence: 99%
“…The mean ablation time was 99 8. ± 22.7 s. The minimum temperature T A B L E 1 Abbreviations: BMI, body mass index; DM, diabetes mellitus; EF, ejection fraction; LAD, left atrial diameter; LAV, left atrial volume; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; PAF, paroxysmal atrial fibrillation; TIA, transient ischemic attack.…”
mentioning
confidence: 99%
“…By comparing NVAF patients with and without SEC, previous studies have identified several risk factors for SEC presence, which are capable of reflecting hemodynamic and hematological status correlated with SEC formation, such as HF/decreased LVEF, LA dilation, increased fibrinogen, C-reactive protein, and D-dimer. 10,[29][30][31] Moreover, severe MR was reported to be protective against SEC owing to the increased shear rate within LA. However, it remained unclear if these parameters were suitable to predict severe SEC.…”
Section: La Hemodynamics and Severe Secmentioning
confidence: 99%